Galaxy Securities of China: First Coverage of Foxconn Interconnect Technology (02696.HK) Receives "Recommended" Rating Domestic and Overseas Business Steadily Advancing

According to the Wisdom Financial APP, China Galaxy Securities published a research report stating that Fuhong Hanlin (02696.HK) was founded in 2010, focusing on areas such as hematologic malignancies, solid tumors, and autoimmune diseases. It is the first domestic company to layout biosimilars. Since 2018, the company has actively cooperated with overseas manufacturers to promote the internationalization of biosimilars and innovative drugs. Products represented by rituximab have been approved and marketed in more than 50 countries and regions worldwide. They have been rated as "recommended" for the first time.